Cancer
Fluoropyrimidines (5-fluorouracil, capecitabine)
Antimetabolites that starve dividing cells of thymidine for DNA; the backbone of chemotherapy for colorectal cancer, including cancer that has spread to the liver.
Mechanism of action
- 5-Fluorouracil (5-FU) is inactive as given and is converted inside cells to several nucleotides.
- One of them, FdUMP, binds thymidylate synthase covalently together with the folate cofactor 5,10-methylenetetrahydrofolate, blocking the enzyme.
- Without thymidylate, DNA cannot be made: “thymineless death” of dividing cells.
- Other metabolites are built into RNA and DNA, adding RNA- and DNA-mediated damage.
- Capecitabine is an oral prodrug turned into 5-FU in three steps, the last by thymidine phosphorylase, an enzyme more active in many tumours, such as colorectal cancer, than in normal tissue.
Molecular targets
- Thymidylate synthase: Inhibited by the metabolite FdUMP (covalent ternary complex)
Drugs in Fluoropyrimidines (5-fluorouracil, capecitabine)
- 5-Fluorouracil (Given intravenously, by infusion.)
- Capecitabine (Oral prodrug of 5-FU.)
Therapeutic uses
- Metastatic colorectal cancer, alone or combined with oxaliplatin or irinotecan (with leucovorin)
- Adjuvant treatment after surgery for stage III, and high-risk stage II, colon cancer
- Metastatic breast cancer (capecitabine)
- Gastric adenocarcinoma, in combination with a platinum drug
- Superficial basal cell carcinoma and actinic keratoses: fluorouracil cream
Diseases it treats
Pharmacokinetics
- 5-FU has a very short half-life, about 10 to 15 minutes, so infusion schedules are generally preferred to bolus doses.
- Up to 80–85% of 5-FU is broken down by dihydropyrimidine dehydrogenase (DPD).
Adverse effects
- Myelosuppression, nausea and vomiting, mucositis, diarrhoea and alopecia
- Capecitabine: mainly diarrhoea and the hand-foot syndrome
Contraindications by condition
- DPD deficiency (Contraindicated): Without the enzyme that breaks it down, fluorouracil accumulates: severe myelosuppression, mucositis and neurotoxicity.
- Pregnancy (Contraindicated): It is teratogenic.
- Taking warfarin (capecitabine) (Use with care): Capecitabine increases the effect of warfarin: bleeding.
Connected topics
Written from
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 54, Cancer Chemotherapy, Antimetabolites: fluoropyrimidines
Educational reference. Not medical advice, diagnosis or treatment.